CAS: 339086-80-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Tadocizumab REF: TM-T76979CAS: 339086-80-5 | - - - | 279.00 €~2,511.00 € | Mon 02 Dec 24 |
 | Tadocizumab REF: 3D-CLA1084CAS: 339086-80-5 | - - - | To inquire | Tue 10 Dec 24 |
Tadocizumab
CAS:339086-80-5
Tadocizumab (C4G1) is a humanized monoclonal antibody targeting integrin αIIbβ3 with antiplatelet and antithrombotic effects.
Color and Shape:
Liquid
Ref: TM-T76979
| 1mg | 279.00 € | ||
| 5mg | 675.00 € | ||
| 10mg | 921.00 € | ||
| 25mg | 1,391.00 € | ||
| 50mg | 1,839.00 € | ||
| 100mg | 2,511.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
Tadocizumab
CAS:339086-80-5
Anti-IL-6 receptor humanized whole antibody, immunosuppressive drug, treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis …
Ref: 3D-CLA1084
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
